Nrf-2 activates antioxidant enzymes and upregulates Notch-1 through the G6PD/HIF-1 pathway, thereby affecting the proliferation of breast cancer cells (Zhang et al., 2019a). This evidence concerns the gene NFE2L2 and breast carcinoma.